NBW Capital’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-51,582
Closed -$2.33M 88
2021
Q2
$2.33M Sell
51,582
-42,403
-45% -$1.88M 0.57% 69
2021
Q1
$4.53M Buy
93,985
+9,184
+11% +$478K 1.25% 35
2020
Q4
$4.57M Sell
84,801
-39,465
-32% -$1.78M 1.39% 30
2020
Q3
$4.58M Buy
124,266
+940
+0.8% +$34.9K 1.53% 25
2020
Q2
$3.82M Buy
+123,326
New +$3.42M 1.37% 31

Other funds holding NEO

NBW Capital's NEO Position: Q3 2021 in Review

NBW Capital sold out of NeoGenomics (NEO) in Q3 2021, closing a stake of 51,582 shares — an estimated $2.33M sold.

NBW Capital first reported a position in NEO in Q2 2020 and held it in 5 quarters. The position peaked at $4.58M in Q3 2020. 324 funds tracked by Wall St. Rank hold NEO as of Q3 2021.

  • NBW Capital reported no remaining NeoGenomics position as of Q3 2021 after selling out during the quarter.
  • NBW Capital sold 51,582 NeoGenomics shares in Q3 2021, an estimated $2.33M.
  • NBW Capital first reported a position in NeoGenomics in Q2 2020 and held it in 5 quarters.
  • NBW Capital's NeoGenomics position peaked at $4.58M in Q3 2020.
  • 324 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2021.

Based on NBW Capital's 13F filing for Q3 2021, filed 3 Nov 2021.